IMAX Co. (NYSE:IMAX – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 4,850,000 shares, an increase of 12.8% from the September 15th total of 4,300,000 shares. Based on an average trading volume of 737,400 shares, the short-interest ratio is currently 6.6 days. Currently, 11.5% of the shares of the company are sold short.
IMAX Price Performance
Shares of NYSE:IMAX opened at $21.25 on Tuesday. The firm has a fifty day moving average price of $20.49 and a two-hundred day moving average price of $18.24. The company has a market cap of $1.12 billion, a price-to-earnings ratio of 44.27, a PEG ratio of 1.41 and a beta of 1.25. IMAX has a one year low of $13.20 and a one year high of $22.13.
IMAX (NYSE:IMAX – Get Free Report) last posted its quarterly earnings data on Thursday, July 25th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.11. The company had revenue of $88.96 million during the quarter, compared to analyst estimates of $74.52 million. IMAX had a return on equity of 7.78% and a net margin of 5.97%. The firm’s quarterly revenue was down 9.2% on a year-over-year basis. During the same quarter last year, the company earned $0.17 earnings per share. Equities research analysts expect that IMAX will post 0.69 EPS for the current fiscal year.
Institutional Trading of IMAX
Analyst Upgrades and Downgrades
IMAX has been the subject of several research reports. JPMorgan Chase & Co. increased their price objective on IMAX from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday. Barrington Research reissued an “outperform” rating and issued a $24.00 price objective on shares of IMAX in a report on Wednesday, September 25th. Wedbush upped their price objective on shares of IMAX from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, September 3rd. Macquarie lifted their target price on shares of IMAX from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Friday, July 26th. Finally, B. Riley upped their price target on shares of IMAX from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Monday, July 8th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.11.
Get Our Latest Analysis on IMAX
About IMAX
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Articles
- Five stocks we like better than IMAX
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Outerwear Stocks to Warm Up Your Portfolio for the Winter
- Trading Halts Explained
- Dining Out, Cashing In: 2 Restaurant Stocks Leading the Pack
- Stock Average Calculator
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.